Mast cells and e{open}PKC: A role in cardiac remodeling in hypertension-induced heart failure

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 6, 2008, Pages 779-786

  Palaniyandi, Suresh Selvaraj ^a   Inagaki, Koichi ^a   Mochly Rosen, Daria ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac remodeling; Heart failure; Mast cell degranulation; PKC selective inhibitor peptide; Protein kinase C

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA N ACETYLHEXOSAMINIDASE; CHYMASE; COMPOUND 48-80; GLUTAMYLALANYLVALYLSERYLLEUCYLLYSYLPROLYLTHREONINE; OLMESARTAN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; IMIDAZOLE DERIVATIVE; PRKCE PROTEIN, RAT; PROTEIN KINASE INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DIETARY INTAKE; DISEASE COURSE; ENZYME ASSAY; ENZYME INHIBITION; FEMALE; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SALT INTAKE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DEGRANULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; MALE; METABOLISM; PATHOLOGY; TIME;

RATTUS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL DEGRANULATION; HEART FAILURE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMIDAZOLES; MALE; MAST CELLS; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED DAHL; SIGNAL TRANSDUCTION; TETRAZOLES; TIME FACTORS;

EID: 55649123455     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.08.009     Document Type: Article

References (41)

1. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
2. Knecht M., Burkhoff D., Yi G.H., Popilskis S., Homma S., Packer M., et al. Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs. J Mol Cell Cardiol 29 (1997) 217-227
3. Jordana M., Befus A.D., Newhouse M.T., Bienenstock J., and Gauldie J. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43 (1988) 552-558
4. Ruoss S.J., Hartmann T., and Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin. Invest. 88 (1991) 493-499
5. Petrov V.V., Fagard R.H., and Lijnen P.J. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39 (2002) 258-263
6. Palaniyandi S.S., Nagai Y., Watanabe K., Ma M., Veeraveedu P.T., Prakash P., et al. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats. Exp. Biol. Med. 232 (2007) 1213-1221
7. Janicki J.S., Brower G.L., Gardner J.D., Forman M.F., Stewart Jr. J.A., Murray D.B., et al. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc. Res. 69 (2006) 657-665
8. Vilcek J., Palombella V.J., Henriksen-DeStefano D., Swenson C., Feinman R., Hirai M., et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med. 163 (1986) 632-643
9. Patella V., Marino I., Arbustini E., Lamparter-Schummert B., Verga L., Adt M., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97 (1998) 971-978
10. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. 6 (2006) 218-230
11. Chang E.Y., Szallasi Z., Acs P., Raizada V., Wolfe P.C., Fewtrell C., et al. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3. J. Immunol 159 (1997) 2624-2632
12. Ludowyke R.I., Elgundi Z., Kranenburg T., Stehn J.R., Schmitz-Peiffer C., Hughes W.E., et al. Phosphorylation of nonmuscle myosin heavy chain IIA on Ser1917 is mediated by protein kinase C beta II and coincides with the onset of stimulated degranulation of RBL-2H3 mast cells. J. Immunol. 177 (2006) 1492-1499
13. Inagaki K., Koyanagi T., Berry N.C., Sun L., and Mochly-Rosen D. Pharmacological Inhibition of {epsilon}-Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure. Hypertension (2008)
14. Johnson J.A., Gray M.O., Chen C.H., and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271 (1996) 24962-24966
15. Dorn II G.W., Souroujon M.C., Liron T., Chen C.H., Gray M.O., Zhou H.Z., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. PNAS 96 (1999) 12798-12803
16. Brandman R., Disatnik M.H., Churchill E., and Mochly-Rosen D. Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J. Biol. Chem. 282 (2007) 4113-4123
17. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. PNAS 98 (2001) 11114-11119
18. Qi X., Inagaki K., Sobel R.A., and Mochly-Rosen D. Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J. Clin. Invest. 118 (2008) 173-182
19. Begley R., Liron T., Baryza J., and Mochly-Rosen D. Biodistribution of intracellularly acting peptides conjugated reversibly to Tat. Biochem. Biophys. Res. Commun. 318 (2004) 949-954
20. Inagaki K., Iwanaga Y., Sarai N., Onozawa Y., Takenaka H., Mochly-Rosen D., et al. Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. J. Mol. Cell Cardiol. 34 (2002) 1377-1385
21. Inagaki K., Begley R., Ikeno F., and Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation. 111 (2005) 44-50
22. Palaniyandi S.S., Watanabe K., Ma M., Tachikawa H., Kodama M., and Aizawa Y. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur. J. Immunol. 34 (2004) 3508-3515
23. Eghbali M., Tomek R., Sukhatme V.P., Woods C., and Bhambi B. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ. Res. 69 (1991) 483-490
24. Lindstedt K.A., Wang Y., Shiota N., Saarinen J., Hyytiainen M., Kokkonen J.O., et al. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB. J. 15 (2001) 1377-1388
25. Engels W., Reiters P.H., Daemen M.J., Smits J.F., and van der Vusse G.J. Transmural changes in mast cell density in rat heart after infarct induction in vivo. J. Pathol. 177 (1995) 423-429
26. Frangogiannis N.G., Perrard J.L., Mendoza L.H., Burns A.R., Lindsey M.L., Ballantyne C.M., et al. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation. 98 (1998) 687-698
27. Lindstedt K.A., Mayranpaa M.I., and Kovanen P.T. Mast cells in vulnerable atherosclerotic plaques-a view to a kill. J. Cell Mol. Med. 11 (2007) 739-758
28. Brower G.L., Chancey A.L., Thanigaraj S., Matsubara B.B., and Janicki J.S. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am. J. Physiol. 283 (2002) H518-525
29. Palaniyandi Selvaraj S., Watanabe K., Ma M., Tachikawa H., Kodama M., and Aizawa Y. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy. Biol. Pharm. Bull. 28 (2005) 2128-2132
30. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., Davis S.E., Gatewood S.J., et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am. J. Pathol. 165 (2004) 1883-1894
31. Matsumoto T., Wada A., Tsutamoto T., Ohnishi M., Isono T., and Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 107 (2003) 2555-2558
32. Razin E., Szallasi Z., Kazanietz M.G., Blumberg P.M., and Rivera J. Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. PNAS 91 (1994) 7722-7726
33. Ozawa K., Yamada K., Kazanietz M.G., Blumberg P.M., and Beaven M.A. Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J. Biol. Chem. 268 (1993) 2280-2283
34. Lessmann E., Leitges M., and Huber M. A redundant role for PKC-epsilon in mast cell signaling and effector function. Inter. Immunol. 18 (2006) 767-773
35. Cho S.H., Woo C.H., Yoon S.B., and Kim J.H. Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells. J. Allergy Clin. Immunol. 114 (2004) 1085-1092
36. Leitges M., Gimborn K., Elis W., Kalesnikoff J., Hughes M.R., Krystal G., et al. Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation. Mol. Cell Biol. 22 (2002) 3970-3980
37. Gray M.O., Zhou H.Z., Schafhalter-Zoppoth I., Zhu P., Mochly-Rosen D., and Messing R.O. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J. Biol. Chem. 279 (2004) 3596-3604
38. Ways D.K., Kukoly C.A., deVente J., Hooker J.L., Bryant W.O., Posekany K.J., et al. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95 (1995) 1906-1915
39. Pass J.M., Gao J., Jones W.K., Wead W.B., Wu X., Zhang J., et al. Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. Am. J. Physiol. 281 (2001) H2500-H2510
40. Pass J.M., Zheng Y., Wead W.B., Zhang J., Li R.C., Bolli R., et al. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am. J. Physiol. 280 (2001) H946-H955
41. Batlle M., Perez-Villa F., Lazaro A., Garcia-Pras E., Ramirez J., Ortiz J., et al. Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients. Transplant. Proc. 39 (2007) 2347-2349